HEIDI ROMERO: Open Payments
NPI 1306607908 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,446 in 117 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $1,978 · 2025 $2,446
Food & beverage: $2,446
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 20 | $358 |
| Vanda Pharmaceuticals Inc. | 10 | $350 |
| Otsuka America Pharmaceutical, Inc. | 15 | $314 |
| ABBVIE INC. | 25 | $231 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $196 |
| E.R. Squibb & Sons, L.L.C. | 5 | $162 |
| Axsome Therapeutics, Inc. | 5 | $139 |
| Teva Pharmaceuticals USA, Inc. | 1 | $123 |
| Biogen, Inc. | 1 | $105 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $93 |
Products named: FANAPT, ARISTADA, REXULTI, VRAYLAR, CAPLYTA, COBENFY, Auvelity, UZEDY.
Industry payments across LA — which companies pay providers there.
